New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
Offering improved functionality of existing radiology information systems (RIS), a new partnership between RamSoft and Alpha Nodus may significantly enhance radiology workflow and address the time-consuming nature of prior authorizations.
RamSoft said the integration of the Gravity AI (Alpha Nodus) tools into its RIS offerings will streamline radiology workflows through increased automation. Alpha Nodus maintained that artificial intelligence (AI)-powered automation will reduce the burden of prior authorizations in radiology.
“Prior authorizations once took hours or even days," said Shamit Patel, the CEO of Alpha Nodus. "With Gravity, now integrated into PowerServer, we've fully automated or reduced that to just minutes, improving efficiency and accelerating the patient journey."
The companies said key benefits of the integration will include:
• real-time verification of payer requirements to prevent delays
• AI-enabled patient scheduling to reduce no-shows
• up to a 25 percent reduction of claim denial rates through compliance checks
RamSoft and Alpha Nodus will be showcasing the updated software at the Radiology Business Management Association (RBMA) Paradigm 2025 conference through March 27.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
